About the HWIFC Cancer Research Group

The HWIFC Cancer Research Group is a not-for-profit research organization that formed 3 years ago as a result of a growing desire to understand the root of this disease.  The focus of our research is to better understand, interrupt, and ultimately halt its progression.  It is a strong passion of the CRG to investigate the biochemical mechanisms involved with cancer progression and to develop individual treatment strategies that have an impact on the immune system at a cellular level.

Our current research at CRG involves harvesting essential elements of the immune system and enhancing their cancer fighting properties on an individual basis. The identification, isolation and development of immune enhancing cell lines in order to improve an individual’s cancer fighting capability, including cellular surveillance, immune-editing and augmentation is our current focus. We are investigating the use of autologous peptide and cytokine-based vaccines in combination with intravenous immunotherapy to upregulate the immune system on a multitude of levels.

All research is privately sponsored and funded through the Cancer Research Group and under private study. We are not affiliated with any vaccine-development industry, pharmaceutical industry, or medical biotech-related industry. I invite you to assist us with the development of these cancer fighting strategies by supporting this vital, integrative research. If you are interested in making a donation, please click on how you can help above. We thank you for your continued support of the HWIFC Cancer Research Group, where medical science and integrative therapies come together to help reach a cure.

Our mission is to offer innovative cancer research that offers integrative, immune enhancing therapies in a personalized environment that fosters hope for cancer patients, survivors and loved ones.
web solutions : redtopia